Sickle Cell Disease Regional Care Excellence (SoRCE) Program
Agency: Health Resources and Services Administration
Assistance Listings: 93.365 -- Sickle Cell Treatment Demonstration Program
Last Updated: June 5, 2026
Description
Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to adulthood...
many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH). Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care.
Eligibility
Eligible applicants
Education
- Public and state institutions of higher education
- Private institutions of higher education
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
Miscellaneous
- Other
Additional information
Hospitals or clinicsHealth centers.
Grantor contact information
Description
MCHB
scdprograms@hrsa.gov
scdprograms@hrsa.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| HRSA-26-052_Final.pdf | HRSA-26-052 Final.pdf | Jun 5, 2026 04:52 PM UTC |
| FAQs_-_SoRCE_Questions_6.11.26.pdf | FAQs - SoRCE Questions_6.11.26.pdf | Jun 17, 2026 04:54 PM UTC |
Link to additional information
--
Closing: July 8, 2026
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Award
$6,650,000
Program Funding
7
Expected awards
$--
Award Minimum
$950,000
Award Maximum
Funding opportunity number:
HRSA-26-052
Cost sharing or matching requirement:
No
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
1
Posted date:
June 5, 2026
Archive date:
August 30, 2026
